No Data
Reported Earlier, BeiGene Secures Global Licensing Agreement For Novel MAT2A Inhibitor SYH2039 To Target MTAP-Deleted Solid Tumors
Announcement Highlights | Air China Limited has completed the issuance of over 0.85 billion A-shares to AVIC Group; CHINA RES LAND's sales in November increased by nearly 7% year-on-year.
In the first 11 months, SINO-OCEAN GP's cumulative contracted sales amounted to approximately 30.6 billion yuan, with 3.73 billion yuan in contract sales for November; CHINA RES LAND's total contract sales amount for November was approximately 25.8 billion yuan, representing a year-on-year increase of 6.9%.
Featured announcements | Kanzhun revenue increased 19% year-on-year in the third quarter; China Taibao's original premium income during the year exceeded 410 billion yuan
Xinyi Glass and Xinyi Auto Glass (Hong Kong) signed a 2024 glass supply agreement; CGN Energy completed a cumulative total of 17,684.1 gigawatt-hours of power generation in the first 11 months, an increase of 1.7% over the previous year.
Hong Kong Stock Report, December 12: KPMG expects Hong Kong listed companies to raise more than 100 billion dollars next year, and Kaisa discloses the progress of overseas debt restructuring
① The Legislative Council of the Hong Kong Special Administrative Region passed the “Stamp Duty Legislation (Miscellaneous Amendments) Bill 2024” ② KPMG expects to raise capital of HK$100 billion for listed companies in Hong Kong ③ KPMG discloses progress in overseas debt restructuring ④ Bitcoin market strengthens again and rises back to 0.1 million US dollars
Announcement Highlights | Suoteng Juchuang plans to issue shares at a discount of 7.96% to raise a net amount of 0.271 billion Hong Kong dollars; SenseTime intends to issue shares at a discount of nearly 6.3% to raise 2.787 billion Hong Kong dollars.
From January to November, China Life Insurance's accumulated original insurance premium income was approximately 644.3 billion yuan, a year-on-year increase of 4.8%; YUZHOU GROUP's accumulated contract sales from January to November were 7.247 billion yuan, with sales of 0.781 billion yuan in November.
Reported Earlier, BeiGene Highlights Long-Term BRUKINSA Efficacy And Pipeline Innovations For CLL At ASH 2024